Exchange
Hypotheses
Top-ranked hypotheses by composite score. Filter by lifecycle status, disease, or target gene; sort by score or recency. Click a row to open evidence, scoring detail, and any live prediction markets referencing it.
2
total hypotheses
| # | Hypothesis | Target gene | Status | Composite | Updated | |
|---|---|---|---|---|---|---|
| 1 | STING Antagonists as ALS Therapeutics: Drug Repurposing neuroinflammation 13 ev h-6fe30c39bc | STING (TMEM173) | validated | 0.821 | 2026-05-14 | Open → |
| 2 | Temporal cGAS-STING Activation Stage-Specific Therapeutic Targeting neuroinflammation 7 ev h-cfcf4d4c0d | STING (TMEM173) | proposed | 0.560 | 2026-05-14 | Open → |